Key facts
| Recalling firm | Spacelabs Healthcare, Inc. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Brand Name: Xhibit Product Name: Xhibit Central Station Model/Catalog Number: 96102 Software Version: N/A Product Description: The Spacelabs Healthcare (Spacelabs) Xhibit Central Station, Model 96102. Xhibit offers remote surveillance of patient data for those patients connected to a Spacelabs Healthcare bedside monitors and telemetry systems. The DisplayPort audio/video splitter allows users to extend the audio/video source from the Xhibit to additional external displays or monitors. This extension of audio/video is for viewing only and does not allow interaction with the Xhibit. Component: The DisplayPort audio/video splitter is a 3rd party external accessory to Xhibit. |
| Classification | Class II |
| Recall number | Z-2916-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Due to off-the-shelf display port component that has audio/video failures |
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Brand Name: Xhibit Product Name: Xhibit Central Station Model/Catalog Number: 96102 Software Version: N/A Product Description: The Spacelabs Healthcare (Spacelabs) Xhibit Central Station, Model 96102. Xhibit offers remote surveillance of patient data for those patients connected to a Spacelabs Healthcare bedside monitors and telemetry systems. The DisplayPort audio/video splitter allows users to extend the audio/video source from the Xhibit to additional external displays or monitors. This extension of audio/video is for viewing only and does not allow interaction with the Xhibit. Component: The DisplayPort audio/video splitter is a 3rd party external accessory to Xhibit. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Spacelabs Healthcare, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Spacelabs Healthcare, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Spacelabs Healthcare, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
Spacelabs Healthcare, Inc.’s FDA history
Argus HQ has recorded 3 total FDA actions tied to Spacelabs Healthcare, Inc.: 0 warning letters, 3 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- What is the recall class for Spacelabs Healthcare, Inc.'s recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Why was Brand Name: Xhibit Product Name: Xhibit Central Station Mo recalled?
- FDA's recall record states the reason as: Due to off-the-shelf display port component that has audio/video failures
- Who should I contact about this recall?
- Contact Spacelabs Healthcare, Inc. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
- Has Spacelabs Healthcare, Inc. had other FDA recalls or enforcement actions?
- Yes. Argus HQ has recorded 3 total FDA actions tied to Spacelabs Healthcare, Inc., including 3 recalls and 0 warning letters.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Spacelabs Healthcare, Inc.Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Class II Recall: Brand Name: Xhibit Product Name: Xhibit Central Station… by Spacelabs Healthcare, Inc.. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/spacelabs-healthcare-z-2916-2026-2026-08-19
"FDA Class II Recall: Brand Name: Xhibit Product Name: Xhibit Central Station… by Spacelabs Healthcare, Inc.." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/spacelabs-healthcare-z-2916-2026-2026-08-19.
Argus HQ Research. "FDA Class II Recall: Brand Name: Xhibit Product Name: Xhibit Central Station… by Spacelabs Healthcare, Inc.." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/recall/spacelabs-healthcare-z-2916-2026-2026-08-19.
@misc{argushq_argushq_ai_recall_spacelabs_healthcare_z_2916_2026_2026_08_19_2026,
title = {FDA Class II Recall: Brand Name: Xhibit Product Name: Xhibit Central Station… by Spacelabs Healthcare, Inc.},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/spacelabs-healthcare-z-2916-2026-2026-08-19},
note = {Accessed: August 27, 2026}
}Source: FDA.gov — Recalls ↗

